Allyx Therapeutics anuncia expansão na pesquisa clínica da doença de Parkinson com o composto ALX-001 após aceitação do IND

Tue, March 5, 2024 - Allyx Therapeutics Announces Expansion into Parkinson’s Disease Clinical Research with Compound ALX-001 Following IND Acceptance.